KRAS and sarcoma: Hettmer and colleagues demonstrated that SCs, if triggered by particular oncogenic lesions (activation of Kras(G12V) and deletion of p16INK4Ap19ARF), can generate murine sarcomas that are very similar to human nonalveolar RMS with pleomorphic features [57].